Oxidative phosphorylation as a potential therapeutic target for cancer therapy-Reference-Cited by-同舟云学术

Oxidative phosphorylation as a potential therapeutic target for cancer therapy

Published:2019-09-11 Issue:1 Volume:146 Page:10-17
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sica Valentina¹²³^ORCID,Bravo‐San Pedro José Manuel¹²³,Stoll Gautier¹²³,Kroemer Guido¹²³⁴⁵^ORCID

Affiliation:

1. Equipe labellisée par la Ligue contre le cancerUniversité de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers Paris France

2. Team “Metabolism, Cancer & Immunity”équipe 11 labellisée par la Ligue contre le Cancer Paris France

3. Metabolomics and Cell Biology PlatformsInstitut Gustave Roussy Villejuif France

4. Pôle de BiologieHôpital Européen Georges Pompidou, AP‐HP Paris France

5. Suzhou Institute for Systems MedicineChinese Academy of Sciences Suzhou China

Funder

Institut Universitaire de France

Institut National de la Santé et de la Recherche Médicale

Institut National Du Cancer

Association pour la Recherche sur le Cancer

Agence Nationale de la Recherche

Ligue Contre le Cancer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32616

Reference65 articles.

1. Tumor Cell Metabolism: Cancer's Achilles' Heel

2. Metabolic targets for cancer therapy

3. Cancer metabolism at a glance

4. Targeting Metabolism for Cancer Therapy

5. Targeting cancer metabolism: a therapeutic window opens

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment;Genes & Diseases;2024-03

2. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses;Cell Biochemistry and Function;2024-01-28

3. Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells;2024-01-05

4. Extracellular Guanosine and Guanine Nucleotides Decrease Viability of Human Breast Cancer SKBR-3 Cells;Biological and Pharmaceutical Bulletin;2024-01-01

5. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells;American Journal of Physiology-Cell Physiology;2023-12-01